Skip to main content

Advertisement

Fig. 1 | BMC Neuroscience

Fig. 1

From: Additive effect of 5-HT2C and CB1 receptor blockade on the regulation of sleep–wake cycle

Fig. 1

The effects of SB-242084 (SB, 1 mg/kg ip.) and AM-251 (AM D5, 5 mg/kg ip. and AM D10, 10 mg/kg ip.) treatments on the time spent in a active wakefulness (AW); b passive wakefulness (PW); c light slow wave sleep (SWS-1); d deep slow wave sleep (SWS-2); e rapid eye movement sleep (REMS); f intermediate stage of sleep (IS) in the summarized first 2 h of the passive phase. Data are presented as mean ± SEM of the 6 animals. *p < 0.05, **p < 0.01, ***p < 0.001 compared to the veh + veh control group (Dunnett’s post hoc comparison)

Back to article page